Connect with us

Technology

Invenio Imaging Announces First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer

Published

on

SANTA CLARA, Calif., Aug. 9, 2024 /PRNewswire/ — Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the enrollment of the first patients in a US pivotal study of its AI-based image analysis module for lung cancer. The ON-SITE study, a multicenter study in bronchoscopy combining Stimulated Raman Histology with Artificial Intelligence for rapid lung cancer detection, is in collaboration with Johnson & Johnson Enterprise Innovation Inc. and will be conducted at multiple centers including The University of Texas MD Anderson Cancer Center, Corewell Health, Memorial Sloan Kettering Cancer Center, and University of North Carolina at Chapel Hill.

Invenio aims to develop the first FDA-cleared AI to identify cell/tissue morphology suspicious for cancer in lung biopsies

Lung cancer is the leading cause of cancer-related deaths in the United States. This has led to the institution of large-scale screening programs for high-risk patients, which results in an estimated 3.1 million new primary lung nodules identified each year. Despite major sector investment in minimally-invasive biopsy technology, obtaining adequate tissue for biomarker and treatment determination remains a challenge. For this reason, bronchoscopy guidelines recommend rapid-on-site tissue evaluation (ROSE) for lung biopsies.

“ROSE requires that a cytologist or highly trained cytotechnician be physically present in the procedure room, and thus it is not available at many centers performing lung biopsy due to resource limitations,” said Jason Akulian, MD, Director of Interventional Pulmonlogy at UNC, “we are excited by the NIO’s potential to extend the benefits of ROSE to the proceduralist when the service is not available.”

The NIO® Laser Imaging System allows rapid imaging of fresh tissue biopsies in the treatment room. Sample preparation does not require staining or sectioning and can be performed by the existing OR-staff. NIO® Slides are also designed to allow retrieval of the sample for downstream analysis. NIO® images are natively digital and can be shared in near real-time. The ON-SITE study aims to develop and validate an AI-based image analysis module for the NIO® Laser Imaging System that is intended to assist physicians in the detection of cancer in bronchoscopic lung biopsies in situations where ROSE is not available for the sample type.

“Artificial intelligence aiding healthcare may seem utopic, but the future is coming. While still investigational, the promise of fast, in-room, accurate identification of tissue that is suspicious for cancer has the potential to ultimately lead to improved outcomes, a beneficial cost/benefit profile, and personalized treatments,” said Gustavo Cumbo-Nacheli, MD, pulmonologist at Corewell Health and one of the site PIs for the ON-SITE study.

“Enrolling the first patient in the ON-SITE study is an important milestone for Invenio, as we aim to develop the first FDA-cleared AI to identify cell/tissue morphology suspicious for cancer in lung biopsies,” said Jay Trautman, PhD, co-founder and CEO of Invenio Imaging. “Near real-time image analysis on the NIO® Laser Imaging System completes the end-to-end solution for streamlined intraoperative histology.”

About Invenio Imaging Inc.

Invenio Imaging is an emerging, privately held medical device company based in Santa Clara (CA) dedicated to advancing the care of cancer patients by combining intraoperative fresh tissue imaging and artificial intelligence. The NIO® Laser Imaging System is FDA-registered and CE-marked and has been used in over 10,000 procedures across neurosurgery, bronchoscopy, urology, and endoscopy. Invenio Imaging’s first AI product, the NIO® Glioma Reveal, has received CE mark and is available for clinical use in Europe. The AI product for lung cancer that is the subject of the ON-SITE study has not been approved for clinical use. Invenio received a Medical Design Excellence Award and was selected for the Rosenman Innovator and MedTech Innovator cohorts.

Disclaimer 

Research reported in this press release is supported by the National Cancer Institute of the National Institutes of Health under Award Number 1R44CA281581-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

View original content:https://www.prnewswire.com/news-releases/invenio-imaging-announces-first-patients-enrolled-in-us-pivotal-study-of-ai-based-image-analysis-module-for-lung-cancer-302218302.html

SOURCE Invenio Imaging

Continue Reading

Technology

“Shenzhen: Where the Future Takes Shape” Released to Mark the APEC Economic Leaders’ Meeting

Published

on

By

SHENZHEN, China, Nov. 16, 2026 /PRNewswire/ — On Nov. 15, as the 2026 APEC Economic Leaders’ Week got underway, host city Shenzhen released its promotional film “Shenzhen: Where the Future Takes Shape.”

Presented by the Publicity Department of the CPC Shenzhen Municipal Committee and produced by Shenzhen Media Group, the film takes shaping the future as its central theme. It showcases Shenzhen’s efforts to pilot new approaches and set an example for other cities, along with its progress in building a modern, people-centered city, through the lens of the APEC China 2026 theme, “Building an Asia-Pacific Community to Prosper Together.” It offers audiences across the Asia-Pacific and around the world a vivid look at Chinese modernization in practice.

A follow-up to “Gather in Shenzhen,” the film opens with the question “What will the future look like?” It explores what makes a city innovative, livable, beautiful, resilient, culturally advanced, and smart. Examples and data on the “Shenzhen cycle,” R&D investment, innovation clusters, government services, transport links at ports of entry, and the city’s ecology and culture show how Shenzhen is building a modern city.

Running just over six minutes, the film was shot in 8K ultra-high definition. Of the film’s more than 260 shots, 99% were newly filmed in 2026. The crew filmed across Shenzhen’s nine administrative districts, Dapeng New District, and the Shenzhen-Shanwei Special Cooperation Zone, with additional shoots in Hong Kong and Zhongshan. More than 300 residents appear on camera.

The film invites the world to gather in Shenzhen, witness the wonders, and build a better future together.

YouTube Link: https://www.youtube.com/watch?v=juktW8T6B1Q

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/shenzhen-where-the-future-takes-shape-released-to-mark-the-apec-economic-leaders-meeting-302939799.html

SOURCE Shenzhen Media Group

Continue Reading

Technology

TARSBOT and Aptiv Deepen Strategic Collaboration on Embodied AI

Published

on

By

SHANGHAI, Nov. 16, 2026 /PRNewswire/ — During the 9th China International Import Expo (CIIE), TARSBOT and Aptiv signed an agreement to further deepen their strategic collaboration in embodied AI.

Under the agreement, Aptiv expects to complete the deployment of 100-unit TARSBOT A-Series industrial embodied AI robots by the end of this year, covering 8 manufacturing process categories and 33 application scenarios, including flexible assembly, coordinated inspection and production management. The first batch of robots has already entered operation in real production-line environments at an Aptiv smart factory.

In addition, Aptiv products, including high-performance computing platforms, are intended to be introduced into TARSBOT embodied AI robots as a computing foundation to support highly reliable operation in real industrial settings. The parties plan to achieve mass production in 2026.

The two companies will also continue to validate applications in real industrial environments. Insights gained from production will support the iterative development of AWE (AI World Engine), TARSBOT’s general-purpose foundation model for embodied AI.

With the support of the Jiading District Government of Shanghai, TARSBOT and Aptiv have already been working closely to advance the development and scaled deployment of China’s first industrial embodied AI robot fleet with a target scale of 1,000 units. The first phase of the project is being implemented at an Aptiv production site, with the collaboration focused on adapting robots to real production processes and manufacturing requirements. The signing at CIIE marks a more systematic and scaled phase of the cooperation.

As the cooperation deepens, Aptiv’s high-performance computing platforms and intelligent power distribution solutions will be further integrated into TARSBOT embodied AI robots to support stable operation on real production lines. The high-performance computing platforms provide flexible and reliable compute for core robotic functions such as perception, decision-making and motion control. Combining TARSBOT’s end-to-end embodied AI capabilities and experience in real production-line applications with Aptiv’s established engineering expertise and rigorous standards, the collaboration aims to support efficient, reliable deployment at scale.

The collaboration aims to demonstrate that scalable deployment can be validated in practical industrial settings. As manufacturers worldwide face growing demand for intelligent automation and greater supply-chain efficiency, embodied AI is emerging as an important force in advancing next-generation productivity.

Looking ahead, TARSBOT and Aptiv will build on China’s rich real-world manufacturing environments to further connect robotic systems with operational applications. The collaboration aims to provide a validated and scalable industrial reference for replicating and expanding embodied AI across additional scenarios, creating broader opportunities for smart manufacturing worldwide.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/tarsbot-and-aptiv-deepen-strategic-collaboration-on-embodied-ai-302939162.html

SOURCE TARS

Continue Reading

Technology

Thunes Expands Real-Time Payouts to Bhutan, Unlocking the Nation’s Remittance Market

Published

on

By

Thunes’ Direct Global Network enables instant, 24/7 payments to all bank accounts in Bhutan, empowering Members to support the nation’s rapidly expanding remittance corridor.

SINGAPORE and THIMPHU, Bhutan, Nov. 16, 2026 /PRNewswire/ — Thunes, the Smart Superhighway to move money around the world, today announced the expansion of its Direct Global Network into the Kingdom of Bhutan, enabling its Network Members, including digital banks, money transfer operators (MTOs), and remittance service providers, to send real-time Consumer-to-Consumer (C2C) payouts to all licensed bank accounts in the country. 

The direct integration allows Non-Resident Bhutanese and expatriates across Australia, the Middle East, Southeast Asia, and North America to send funds home in Bhutanese Ngultrum (BTN) in seconds, avoiding multi-day clearing cycles and unpredictable intermediary markups. 

For Thunes’ Members, the new connection unlocks three key benefits:

Immediate market reach: Tap into the majority of Bhutan’s remittance volume by enabling person-to-person transfers.24/7 real-time deposits: Send funds to local bank accounts any time of day, eliminating batching delays.Higher payment success rates: Automated account verification and standardized sender data reduce failed transfers and return fees.

With over 70,000 Bhutanese nationals – nearly 10% of the population – living abroad, personal remittances account for 3% to 4% of national GDP and grew 69% from 2024 to 2025. Historically, these flows have relied on complex correspondent banking networks, incurring costs and delays.

With banks as the primary channel to send money home, Thunes clears these payments in seconds, supporting recurring salary transfers, personal savings, and family support for living expenses, healthcare, and education. Every transaction is backed by Thunes’ Fortress Compliance engine for strict AML and regulatory adherence, alongside its SmartX Treasury System for advanced liquidity management. 

Alex Young, Chief Network Officer at Thunes, said: “Bhutan represents a vital corridor where cross-border remittances serve as an indispensable financial lifeline for families. By connecting Bhutan’s entire banking sector directly into our Direct Global Network, we have established an effective, transparent way to ensure hard-earned funds arrive safely, securely, and in real time.”

Eugene Chua, Head of Network, APAC, at Thunes, added: “At Thunes, we are dismantling the friction that creates barriers to the global digital economy. Bhutan’s diaspora has grown significantly, especially across markets like Australia and Southeast Asia. Enabling instant consumer account deposits ensures expatriates have access to a reliable, transparent, and direct payment rail to send money back home.”

About Thunes:

For more information, visit: https://www.thunes.com/

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/thunes-expands-real-time-payouts-to-bhutan-unlocking-the-nations-remittance-market-302939104.html

Continue Reading

Trending